BCL2L11 and non-small cell lung carcinoma: Also, PFS and OS were significantly shorter in NSCLC EGFR-mutated patients with BIM deletion polymorphism (PFS: p< 0.001, HR = 1.37, 95% CI = 1.09–1.71; OS: p = 0.003, HR = 1.25, 95% CI = 1.08–1.45).